Johnson & Johnson
JNJ
Israeli Tech Ecosystem Related
Company Overview
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The MedTech segment offers products used in the interventional solutions. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
Shariah Compliance Benchmarks:
- Business Compliance: Non-Shariah compliant revenue must be less than 5% of total revenue
- Liabilities Compliance: Interest-bearing debt must be less than 33% of market capitalization
This stock meets all Shariah compliance criteria according to AAOIFI standards.
| Revenue Segment | Value ($M) | Non-Compliant ($M) | Reason |
|---|---|---|---|
| Innovative Medicine | $56,964.0 | $0.0 | - |
| MedTech | $31,857.0 | $0.0 | - |
| Interest income | $1,332.0 | $1,332.0 | - |
| Total | $90,153.0 | $1,332.0 | 1.48% (passed) |
| Name | Johnson & Johnson |
| Ticker | JNJ |
| Main Business | Drug Manufacturers—General |
| Type | Common Stock |
| Industry | Drug Manufacturers—General |
| Country | US |
| Market Cap | $377.74 B |
V-Wave
Founded: 2009
Miniature Shunt for Treating Congestive Heart Failure
Omrix Biopharmaceuticals
Founded: 1995
Human Plasma Derived Products
Biosense Webster
Founded: 1993
Diagnosis and Treatment of Cardiac Arrhythmias
FutuRx
Investor
Johnson & Johnson Innovation
Investor
